Strengths and prices
| Strength | Price per vial | Availability | Batch | |
|---|---|---|---|---|
| 10 mg | $21.00 | In stock | BC-2607-0032 | |
| 20 mg | $35.00 | In stock | BC-2607-0017 |
Every vial carries its batch code and a QR that opens the certificate of analysis for that exact batch. No account is needed to read one.
What it is
BPC-157 is a synthetic peptide of 15 amino acids. Its sequence is taken from a larger protein first described in human gastric juice.
Identity
| Type | Synthetic peptide, 15 amino acids |
|---|---|
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular formula | C62H98N16O22 |
| Molecular weight | 1419.5 g/mol |
| CAS number | 137525-51-0 |
| PubChem CID | 9941957 |
BPC-157 is a synthetic linear pentadecapeptide, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, corresponding to a 15-residue segment of a larger gastric protein. Molecular formula C62H98N16O22, molecular weight 1419.5 g/mol (PubChem CID 9941957, CAS 137525-51-0). It contains no cysteine, so it has no disulfide bond, and its five prolines and three acidic residues make it a flexible, acidic, water-soluble peptide. Suppliers sell it as an acetate or arginate salt; the certificate of analysis for a batch states which. It is supplied as a white lyophilized powder in a sealed vial.
What the published research covers
Nearly all published work is in rodents and cell culture, covering tendon, muscle and gastrointestinal tissue models, and much of it comes from one research group. Published human data are very limited.
BPC-157 was first described in the early 1990s by a research group at the University of Zagreb, who reported it as a stable fragment of a protein found in human gastric juice and proposed that it protects the stomach and other organs under stress (Sikiric, 1993). The same group has produced most of the literature since, nearly all of it in rats: models of transected Achilles tendon (Staresinic, 2003), crushed or cut muscle, and gastrointestinal lesions, in which treated animals were reported to recover structure and function faster than controls.
Laboratories outside that group have examined mechanism in cell culture. In rat tendon fibroblasts, the peptide increased outgrowth from tendon explants, cell migration and survival under oxidative stress, with activation of the FAK-paxillin pathway (Chang, 2011). In chick embryos, cultured human endothelial cells and a rat hind-limb ischemia model, it increased vessel formation, which the authors linked to activation of the VEGFR2 receptor (Hsieh, 2017). Reviews from the Zagreb group place these findings in a framework of blood-vessel recruitment and interaction with the nitric oxide system (Sikiric, 2016; Seiwerth, 2018).
What is missing is independent replication at scale and human data. No controlled clinical trial has been published in a peer-reviewed journal, and the few human reports are small and uncontrolled. Pharmacokinetics, stability in solution and any difference between the two salt forms sold by suppliers (acetate and arginate) are thinly documented. The peptide is not approved by any regulator.
Regulatory status
Not approved by the FDA for any use. Supplied for laboratory research only.
Testing and documentation
Identity is confirmed by mass spectrometry and purity by HPLC. The certificate of analysis for the batch is reachable from the code on the vial.
Questions laboratories ask
- What strengths is BPC-157 offered in?
- Vials of 5 mg, 10 mg and 20 mg, as listed on the product page. The amount is stated on the vial label and on the certificate of analysis for that batch.
- Is there a certificate of analysis for each batch?
- Yes. Every batch is tested by an independent laboratory: identity by mass spectrometry and purity by HPLC. The QR code on the vial opens the certificate for that exact batch, and it is also reachable from the product page and from your account. No account is needed to read one.
- What form is it supplied in?
- A lyophilized powder in a sealed vial, for laboratory research use only.
- Who can order, and how does it ship?
- Orders are accepted only under the Research Use Agreement, which is accepted on the account and reaffirmed with every order. Orders ship from Montana; an order paid by card ships the next business day. We ship to addresses in the United States only, by FedEx or USPS, and not to freight forwarders.
References
- Sikiric P et al. (1993). A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal de Physiologie (Paris). PubMed 8298609
- Staresinic M et al. (2003). Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research. PubMed 14554208
- Chang CH et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. PubMed 21030672
- Sikiric P et al. (2016). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current Neuropharmacology. PubMed 27138887
- Hsieh MJ et al. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. PubMed 27847966
- Seiwerth S et al. (2018). BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Current Pharmaceutical Design. PubMed 29998800
How it ships
Ordering
Ordering needs an account. A retail account opens as soon as you request it and costs nothing. You pay by card at checkout, or by invoice before the order ships. A wholesale account is reviewed before it opens.
Research use only
This product is a research chemical sold solely for in-vitro laboratory research by qualified persons. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be administered to any person or animal. Read the full agreement